The Effects of Intramuscular Ozone Injection in Patients with Myofascial Pain Syndrome

Comparison Between the Effects of Intramuscular Injection of Ozone and Lidocain on Pain, Range of Motion and Functional Score of Patients with Myofascial Pain Syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016042113442N10

Enrollment

Registered

2016-09-01

Start date

2016-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myofascial Pain Syndrome. Myalgia (excl. myositis)

Interventions

Intervention 1: Ozone Injection In Trigger Points. Intervention 2: Wet Needling (Lidocaine). Intervention 3: Dry Needling (Without Drug).

Treatment - Drugs

Placebo

Ozone Injection In Trigger Points

Wet Needling (Lidocaine)

Dry Needling (Without Drug)

Eligibility

Sex/Gender

All

Age

25 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 25-60 years old? Presence of active trigger points in the upper trapezius muscles? Unilateral pain? More than 3 months pain Exclusion Criteria: Cognitive disorders? History of radiculopathy, trauma or previous surgery in neck? Previous treatment of trigger points with needling during last 6 months? Past medical history of fibromyalgia, RA, hypothyroidism and DM

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pain. Timepoint: 0- 4 weeks. Method of measurement: visual analogue scale (VAS), point pressure threshold (PPT).;Range of Motion. Timepoint: 0- 4 weeks. Method of measurement: Goniometer.	—

Secondary

Measure	Time frame
Functional Score. Timepoint: 0-4 weeks. Method of measurement: Neck Disability Index (NDI) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Sadeghi

Shahid Beheshti Univeraity of Medical Sciences

sadeghi_fsv@yahoo.com+98 21 2273 1112

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026